GlassScriptPhysician profile
Bhaskar Purushottam
NPI 1982804969
$151,249.08
in general payments reported to CMS, 2019-2025
33 companies · $8,532 in 2025
The $8,532 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $49K · 2021: $18K · 2022: $21K · 2023: $36K · 2024: $8,522 · 2025: $8,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $3,729 · Consulting Fee: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $24,556.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,000.00 |
| Food and Beverage | $3,729.35 |
| Consulting Fee | $3,510.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $115,116.69 | 2019-2025 | Indigo System, Penumbra Coil 400, Penumbra System |
| Abbott Laboratories | $13,686.99 | 2019-2025 | Esprit, Xience Skypoint, Pressurewire |
| Medtronic, INC. | $7,388.69 | 2021-2025 | Corevalve Evolut R, Evercross, Hawkone |
| Abiomed | $5,231.54 | 2019-2025 | Impella |
| W. L. Gore & Associates, INC. | $3,540.18 | 2019-2024 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $1,978.07 | 2019-2025 | Opticross 35, Ranger, Jetstream Sc |
| Philips North America LLC | $1,568.83 | 2022-2025 | Labosys, IV Other |
| Teleflex LLC | $778.78 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $625.79 | 2024-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, True Flow |
| Endologix LLC | $305.05 | 2022-2023 | Ovation Ix Iliac Stent Graft |
| Janssen Pharmaceuticals, INC | $199.66 | 2019-2021 | |
| Stryker Corporation | $123.29 | 2025 | Limflow System |
| Novartis Pharmaceuticals Corporation | $92.16 | 2019-2022 | |
| Medtronic Vascular, INC. | $60.94 | 2019 | |
| Angiodynamics, INC. | $59.45 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $53.65 | 2021 | |
| Chiesi USA, INC. | $52.01 | 2019 | |
| Cordis US Corp. | $50.00 | 2024 | Selution Slrpta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.99 | 2019 | |
| Organogenesis INC. | $36.29 | 2025 | Affinity |
| Amgen INC. | $36.29 | 2019 | |
| Cardiva Medical, INC. | $31.82 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $30.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.04 | 2019-2025 | Camzyos |
| Cardiovascular Systems INC. | $28.64 | 2019 | |
| Becton, Dickinson and Company | $26.58 | 2025 | Rotarexs 6 F X 135 Cm |
| Sanofi-Aventis U.S. LLC | $13.45 | 2019 | |
| Silk Road Medical, INC. | $13.22 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $12.71 | 2020 | |
| Amarin Pharma, INC. | $12.62 | 2020 | |
| Tactile Systems Technology INC | $12.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.94 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$262.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhaskar Purushottam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.